MET and neoplasm: The binding of HGF and c-MET triggers several downstream signaling pathways such as phosphoinositide 3-kinase/threonine-protein kinase (PI3K/AKT) pathway, wingless-related integration site (Wnt) pathway, and other tumor-related functions [4–6].